Bill Sponsor
Senate Bill 596
117th Congress(2021-2022)
Treat and Reduce Obesity Act of 2021
Introduced
Introduced
Introduced in Senate on Mar 4, 2021
Overview
Text
Sponsor
Introduced
Mar 4, 2021
Latest Action
Mar 4, 2021
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
596
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Delaware
Republican
Arkansas
Democrat
Delaware
Republican
Indiana
Republican
Louisiana
Democrat
Michigan
Democrat
Minnesota
Democrat
Minnesota
Republican
Mississippi
Republican
Mississippi
Democrat
New Hampshire
Democrat
New Mexico
Democrat
New Mexico
Republican
North Carolina
Republican
North Dakota
Republican
North Dakota
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Treat and Reduce Obesity Act of 2021

This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner.

The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.

Text (1)
Actions (2)
03/04/2021
Read twice and referred to the Committee on Finance.
03/04/2021
Introduced in Senate
Public Record
Record Updated
Mar 9, 2023 5:47:48 PM